Oncogene Expression in Tumour Cells of Pediatric Hodgkin's Disease in Argentina — Correlation with Epstein Barr Virus Presence
- 31 December 1998
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 194 (1) , 25-31
- https://doi.org/10.1016/s0344-0338(98)80008-3
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international dataInternational Journal of Cancer, 1997
- p53 Expression in Reed-Sternberg Cells Does Not Correlate With Gene Mutations in Hodgkin’s DiseaseAmerican Journal of Clinical Pathology, 1996
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994
- The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhoodAnnals of Hematology, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- An Immunocytochemical Study of p53 and bcl-2 Protein Expression in Hodgkin’s DiseaseAmerican Journal of Clinical Pathology, 1993
- Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease.Proceedings of the National Academy of Sciences, 1993
- The expression of the EBV latent membrane protein (LMP‐1) is independent of CD23 and bcl‐2 in Reed‐Sternberg cells in Hodgkin's diseaseHistopathology, 1992
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- The p53 proto-oncogene can act as a suppressor of transformationCell, 1989